Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Skin, Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00476905
What this trial is testing

Spectral Diagnosis of Cutaneous Malignancy

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 350
Not applicableStudy completedNCT02125669
What this trial is testing

Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
Hautklinik Darmstadt 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07455331
What this trial is testing

Flash Radiotherapy for Skin Cancer

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Basal Cell Carcinoma (BCC)
Jules Bordet Institute 60
Not applicableUnknownNCT03069846
What this trial is testing

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

Who this might be right for
Skin Cancer
Sung Hyun Pyun 150
Not applicableStudy completedNCT00046189
What this trial is testing

Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum

Who this might be right for
Xeroderma PigmentosumBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 301
Testing effectiveness (Phase 2)Study completedNCT04893486
What this trial is testing

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Who this might be right for
BCCs in Gorlin Syndrome Patients
Palvella Therapeutics, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT00108134
What this trial is testing

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Peplin 60
Testing effectiveness (Phase 2)Study completedNCT00961896
What this trial is testing

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00021294
What this trial is testing

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Who this might be right for
Non-melanomatous Skin CancerPrecancerous/Nonmalignant Condition
University of Arizona
Not applicableActive Not RecruitingNCT05133427
What this trial is testing

HIFU for Treatment of Non-nodular and Recurrent BCC

Who this might be right for
Carcinoma, Basal Cell
Joergen Serup 40
Large-scale testing (Phase 3)Study completedNCT03703310
What this trial is testing

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 174
Not applicableUnknownNCT02352428
What this trial is testing

Skin Cancer Screening Education Study

Who this might be right for
Skin TumorsMelanomaBasal Cell Carcinoma+1 more
Association of Dermatological Prevention, Germany 113
Not applicableStudy completedNCT04389112
What this trial is testing

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinomas
University Hospital, Bordeaux 119
Very early researchStudy completedNCT02735356
What this trial is testing

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Who this might be right for
Skin Basal Cell Carcinoma
Jean Yuh Tang 9
Early research (Phase 1)Study completedNCT00023959
What this trial is testing

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+51 more
National Cancer Institute (NCI) 39
Early research (Phase 1)Study completedNCT00103246
What this trial is testing

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

Who this might be right for
LymphomaNon-melanomatous Skin CancerPrecancerous Condition
Case Comprehensive Cancer Center 43
Not applicableStudy completedNCT00003611
What this trial is testing

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Who this might be right for
Non-melanomatous Skin Cancer
Alliance for Clinical Trials in Oncology 129
Testing effectiveness (Phase 2)UnknownNCT04929535
What this trial is testing

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma of Skin Differentiated
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 51
Early research (Phase 1)Study completedNCT00017485
What this trial is testing

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Roswell Park Cancer Institute 6
Testing effectiveness (Phase 2)Looking for participantsNCT07227350
What this trial is testing

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 180
Next Page